health – Market Industry Forecast News

Electronic Health Records Drive Digital Change in the U.S. Long Term Care Software Market

The U.S. long term care software market was valued at approximately USD 2.41 billion in 2025 and is projected to reach USD 4.11 billion by 2033, expanding at a 6.92% CAGR from 2026 to 2033. Market expansion is being supported by the growing use of electronic health records (EHRs), demand for greater operational efficiency, healthcare workforce shortages, rising chronic disease prevalence, and the rapidly increasing geriatric population.

What Is Driving Growth in the U.S. Long Term Care Software Market?

The transition toward digitally enabled long-term care is accelerating as skilled nursing facilities, nursing homes, assisted living providers, and post-acute care organizations seek to manage increasingly complex patient needs with constrained resources. Integrated software platforms help these organizations centralize clinical information, automate administrative processes, coordinate care, and support regulatory compliance.

Electronic health records represent a particularly important component of this transition. LTC providers are increasingly adopting integrated EHR platforms to improve documentation, facilitate care coordination, streamline workflows, and provide healthcare professionals with timely access to patient information.

Technology Is Reshaping Long-Term Care Operations

Technological development is expanding the capabilities of long-term care software beyond basic record management. Interoperability, real-time data exchange, cloud computing, and artificial intelligence (AI) integration are enabling providers to connect information across care settings and make operational and clinical processes more efficient.

Cloud-based deployment is particularly significant because it can provide organizations with scalable access to software without requiring extensive on-premises infrastructure. In 2025, the cloud-based mode of delivery accounted for the largest market share at 41.55%.

Download a free sample report or claim your copy of this full market intelligence report

Staffing Shortages Increase Demand for Healthcare IT

Persistent nursing workforce constraints are another factor encouraging LTC organizations to adopt software solutions. Staffing shortages and professional burnout are increasing pressure on healthcare facilities to accomplish more with limited personnel while maintaining care quality and compliance.

According to data published by the American Association of Colleges of Nursing (AACN), federal authorities projected a shortage of approximately 78,610 full-time registered nurses in 2025 and 63,720 in 2030. Factors associated with this workforce pressure include population aging, increasing patient volumes, and clinician burnout.

Against this backdrop, long-term care software can help providers automate routine administrative activities, standardize documentation, improve staff productivity, and reduce the manual workload associated with care management and compliance processes.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

An Aging Population Is Expanding the Need for Digital Care Infrastructure

Demographic changes are creating sustained demand for long-term care services in the U.S. Older adults have a higher incidence of chronic and neurodegenerative diseases, many of which require continuous monitoring, coordinated treatment, medication management, and long-term clinical oversight.

According to June 2025 statistics from the U.S. Census Bureau, the population aged 65 and older increased by 3.1% between 2023 and 2024, reaching approximately 61.2 million people. Continued growth in the older population is expected to increase pressure on healthcare organizations to manage long-term conditions efficiently.

Chronic and Neurodegenerative Diseases Support Market Expansion

The rising prevalence of Alzheimer’s disease and Parkinson’s disease is further increasing the complexity of long-term care. The 2025 Alzheimer’s Disease Facts and Figures report estimated that approximately 7.2 million Americans aged 65 and older were living with Alzheimer’s dementia in 2025. The number is projected to reach approximately 13.8 million by 2060.

Growing demand for dementia-related care is expected to increase the need for software that supports structured care planning, clinical documentation, compliance reporting, medication management, and coordination between caregivers and healthcare professionals.

The Parkinson’s Foundation estimates that approximately 1 million Americans currently live with Parkinson’s disease, with the number expected to reach 1.2 million by 2030. Approximately 90,000 new diagnoses are estimated each year. These complex, long-duration conditions increase the importance of centralized digital systems for care planning, clinical records, medication management, and resource allocation.

Market Structure: Leading Segments in 2025

Mode of delivery: Cloud-based solutions represented the largest segment, accounting for 41.55% of the market in 2025.
Application: Electronic health records (EHRs) held the largest market share in 2025.
End use: Skilled Nursing Facilities (SNFs) / nursing home

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
Signal (Pricing Intelligence) – Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world’s renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Temperature-Sensitive Drugs Expand the Pharmaceutical Stability And Storage Services Market

The global pharmaceutical stability and storage services market was valued at USD 2.0 billion in 2025 and is projected to reach USD 2.2 billion in 2026 and USD 3.4 billion by 2033, expanding at a 6.5% CAGR from 2026 to 2033. North America accounted for the largest revenue share at 40.1% in 2025, while Asia Pacific is expected to record the fastest growth during the forecast period. Market expansion is being supported by increasingly complex drug development pipelines, growing production of biologics and advanced therapies, and regulatory requirements governing product shelf life, stability, and storage validation.

Market Snapshot

Grand View Research estimates that the pharmaceutical stability and storage services industry will continue expanding as pharmaceutical and biotechnology companies increasingly rely on specialized providers for validated stability programs, controlled storage environments, sample management, and related technical services.

Market Indicator	Value
Market size, 2025	USD 2.0 billion
Estimated market size, 2026	USD 2.2 billion
Projected market size, 2033	USD 3.4 billion
CAGR, 2026–2033	6.5%
Largest region, 2025	North America
North America revenue share, 2025	40.1%
Fastest-growing region	Asia Pacific

What Is Driving Demand?

Several structural factors are contributing to the expansion of pharmaceutical stability and storage services. Pharmaceutical and biotechnology companies are outsourcing more stability and storage activities as drug pipelines become broader and product portfolios become more complex. The increasing development of biologics and advanced therapies is also generating demand for specialized temperature-controlled and validated storage environments.

Clinical trial activity is another important contributor. As development programs generate larger volumes of samples, sponsors require dependable storage capacity and systems that support sample tracking, retrieval, monitoring, and regulatory compliance. Demand is also increasing for cold and ultra-low-temperature storage, recurring commercial stability programs, and stability studies associated with packaging or formulation modifications.

Digital technologies are further changing service requirements. Providers are increasingly expected to offer digital monitoring, compliant sample-management systems, data visibility, and reliable documentation alongside physical storage and testing capabilities.

Download a free sample report or claim your copy of this full market intelligence report

Segment Performance

Small molecules remain the leading molecule segment. The small molecule segment accounted for 79.5% of the market in 2025, reflecting the substantial volume of conventional pharmaceutical products requiring stability evaluation and controlled storage throughout development and commercialization.

Stability testing represents the largest service segment. Stability testing captured 73.5% of the market in 2025, highlighting the central role of stability programs in determining product quality, shelf life, storage conditions, and regulatory readiness.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Regional Landscape

North America represented the largest regional market in 2025, accounting for 40.1% of global revenue. The U.S. held the largest country-level market share during the year.

Asia Pacific is expected to register the highest CAGR from 2026 to 2033. The region’s growth trajectory is supported by expanding pharmaceutical and biotechnology activity and increasing requirements for specialized stability and storage infrastructure.

Market Dynamics: From Basic Storage to Integrated Stability Programs

The pharmaceutical stability and storage services industry is moving beyond standardized room-temperature programs toward a broader range of specialized requirements. Providers increasingly support refrigerated, frozen, ultra-low-temperature, humidity-controlled, photostability, freeze-thaw, and customized study conditions.

This diversification is increasing the importance of capabilities beyond physical storage. Sponsors are placing greater emphasis on technical consultation, protocol development, analytical integration, sample management, digital monitoring, and validated operating procedures.

The purchasing criteria for commercial stability and storage services are also evolving. Business continuity, redundancy, data integrity, response times, monitoring capabilities, deviation management, regulatory inspection readiness, and the ability to accommodate additional samples are becoming important considerations alongside pricing.

Competitive Structure and Service Differentiation

The competitive environment includes both globally integrated laboratory organizations and specialized stability and storage providers.

Integrated organizations can leverage bundled services, cross-selling opportunities, and end-to-end management of stability programs. Specialized providers, meanwhile, can differentiate through dedicated storage capacity, flexible operating models, customized environmental conditions, and faster project onboarding.

Facility location is also becoming strategically important. Developing storage and stability infrastructure close to major pharmaceutical and biotechnology clusters can reduce transportation risks and improve access to samples. As a result, providers are increasingly focusing on technical expertise, scalable capacity, digital transparency, operational reliability, and flexible commercial models.

Companies Profiled

The pharmaceutical stability and storage services market study profiles the following companies:

Catalent, Inc.
Almac Group
Charles River Laboratories
Eurofins Scientific
Intertek Group plc
Lucideon Limited
Alcami Corporation
Element Materials Technology
BioLife Solutions Inc.
Q1 Scientific

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
Signal (Pricing Intelligence) – Commodity price intelligence to drives strategic advantage.

Outdoor Power Equipment Market Supported by Growth in Commercial Projects

The global outdoor power equipment market was estimated at USD 53.42 billion in 2024 and is projected to reach USD 76.61 billion by 2030, registering a compound annual growth rate (CAGR) of 6.3% during 2025–2030. This growth is primarily driven by rising demand for cordless outdoor power tools, as users increasingly seek enhanced flexibility and portability.

Key Market Trends & Insights

Regional leadership: North America generated the highest revenue in 2024
Fastest growing region: Asia Pacific is expected to emerge as the fastest-growing regional market from 2025 through 2030
Dominant equipment type: Lawn mowers held the largest market share by equipment category, accounting for 40.99% in 2024
Growth through end use: Commercial segment usage is expected to grow significantly over the forecast period

Market Size & Forecast

Market size: USD 53.42 billion in 2024
Forecasted size: USD 76.61 billion by 2030
Forecast period CAGR: 6.3% from 2025 to 2030
Leading region: North America was the largest market in 2024
Improvements in technology—especially advancements in battery-powered tools—are expected to further accelerate market growth

Key Companies & Market Share Insight

While specific market shares were not listed in the available content, the market is competitive—with several multinational and diversified manufacturers contributing technological advancements and broad distribution networks.

Order a free sample PDF of the Outdoor Power Equipment Market Intelligence Study, published by Grand View Research.

Key Companies:

Notable players include (in no particular order):
Husqvarna
Makita
Honda Motors
Briggs & Stratton
MTD Holdings
Stanley Black & Decker
Stihl
Techtronic Industries
ECHO (Yamabiko subsidiary)
Ariens
The Toro Company
Deere & Company
Robert Bosch
DexKo Global (which may include AL-KO group affiliates)

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion

The outdoor power equipment market is experiencing solid growth, crossing USD 53 billion in 2024 and forecasted to reach over USD 76 billion by 2030 at a robust CAGR of 6.3%. Key growth drivers include the shift toward battery-powered tools, expanding commercial usage, and strong regional demand—especially from North America and fast-growing Asia Pacific. Lawn mowers dominate the equipment landscape, while a diverse pool of established companies continues to innovate and shape the competitive environment.

browse our blog: https://globalindustryherald.com

Orthobiologics Market Driven by Increasing Adoption in Spine Surgeries

The global orthobiologics market size was estimated at USD 6.77 billion in 2024 and is projected to reach USD 10.34 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.74% from 2025 to 2033. Growth is supported by rising sports injuries, road traffic accidents, widespread adoption of minimally invasive treatments, increasing orthopedic procedures, and a growing aging population.

Orthobiologic products face strict regulatory requirements to ensure they meet high standards of quality, safety, and efficacy before entering the market. This safeguards the patient’s health and fosters trust among healthcare professionals and consumers. Regulatory agencies, such as the Food and Drug Administration (FDA) in the U.S. and the European Medicines Agency (EMA) in Europe, establish guidelines and frameworks for the development, testing, and approval of orthobiologic therapies.

Traditional surgical procedures, while invasive, remain a feasible option for some patients who may not qualify for orthobiologics or those who prefer more established techniques. Additionally, pharmaceutical therapies, such as pain medications and anti-inflammatory drugs, provide non-invasive alternatives for managing symptoms associated with musculoskeletal disorders. Furthermore, medical devices, such as joint implants, provide long-lasting solutions for severe cases of joint degeneration.

Key Market Trends & Insights

North America accounted for the largest regional share at 46.03% of the global orthobiologics market in 2024
By product type, viscosupplementation held the highest share at 42.21% in 2024
Among applications, the spinal fusion segment led with 48.29% share in 2024
Regarding end use, hospitals were dominant in 2024

Market Size & Forecast

2024 Market Size: USD 6.77 billion
2033 Projected Size: USD 10.34 billion
CAGR (2025–2033): 4.74%
Largest Market: North America
Fastest-Growing Region: Europe

Demand Drivers

Sports-related injuries: In 2023, approximately 3.7 million people in the U.S. sustained sports-related injuries
Around 3.5 million children and adolescents incur sports injuries annually out of 30 million participants
Lower extremity injuries—particularly from soccer, track, and cross-country events—are especially common

Order a free sample PDF of the Orthobiologics Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insight

Leading companies shaping the market includes

Medtronic Plc
DePuy Synthes
Zimmer Biomet
Stryker Corporation
Bioventus LLC
Anika Therapeutics, Inc.
Orthofix, Inc.
Globus Medical
Arthrex, Inc.
Bone Biologics Corp.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion

In summary, the orthobiologics market is poised for robust growth, expanding from USD 6.77 billion in 2024 to USD 10.34 billion by 2033 at a CAGR of 4.74%. Growth is propelled by factors such as aging demographics, obesity-related musculoskeletal issues, sports and road-related injuries, and technological progress in regenerative therapies. North America leads in market share, while Europe is emerging swiftly. Viscosupplementation and spinal fusion dominate product and application segments, respectively, with hospitals serving as the primary delivery channel. Innovation, investment, and strategic consolidation among established players further reinforce the market’s upward momentum.

browse our blog: https://globalindustryherald.com

Organic Fruits And Vegetables Market Driven by Rising Fitness Enthusiasts

The global organic fruits and vegetables market was valued at USD 76.19 billion in 2023 and is forecast to grow to USD 147.31 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.9% between 2024 and 2030. This growth is fueled by rising consumer awareness around the health advantages of organic products, worries about food safety, environmental concerns, and a stronger focus on healthy lifestyles.

Key Market Trends & Insights

North America emerged as the dominant region — accounting for 41.6% of global revenue in 2023. In the United States, the market is expected to expand at a CAGR of 9.7% from 2024 through 2030.
By product type, organic fruits represented 57.0% of global revenue in 2023, underscoring their prominent role in this market.
Regarding distribution channels, sales via supermarkets and hypermarkets comprised 52.5% of global revenue in 2023.

Market Size & Forecast

2023 Market Size: USD 76.19 billion
Projected 2030 Market Size: USD 147.31 billion
CAGR (2024–2030): 9.9%
North America held the largest share in 2023.

A 2022 survey estimated total organic food retail sales at around EUR 135 billion (approximately USD 146 billion), reflecting growing consumer shifts toward organic alternatives due to perceived health benefits and safety concerns.

Consumers increasingly favor organic berries such as blueberries and strawberries, which are believed to offer higher antioxidant and phytonutrient levels compared to conventional variants.

Environmental sustainability also plays a pivotal role in fueling demand. Organic produce’s adoption of eco-friendly farming – avoiding synthetic pesticides and promoting soil health – is resonating with consumers aiming to minimize environmental impact and support biodiversity.

In the U.S., consumption of fresh organic produce also continues its upward trajectory. During 2020, fresh organic produce sales rose by nearly 11% to reach USD 18.2 billion.

A specialized winter program was launched by a California-based organic importer in late 2022 to provide organic table grapes from Peru during the off-season, bridging gaps in availability when local grape harvests conclude.

Order a free sample PDF of the Organic Fruits And Vegetables Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insight

The market features a diverse array of participants, from multinational agricultural corporations to regional producers and organic cooperatives. There is notable momentum toward innovation through sustainable farming practices, advances in production technologies, and new organic product offerings.

Examples of farming innovation include precision agriculture, vertical farming, and regenerative methods—all aimed at boosting yields, preserving environmental quality, and nurturing soil vitality.

The industry has also seen consolidation through mergers and acquisitions. A notable example involves a major organic salad producer being acquired by a leading organic food company, enhancing the acquirer’s product range and distribution network.

Regulatory frameworks exert significant influence by establishing standards and building consumer confidence. Certifications such as USDA Organic (U.S.) and the European Union Organic Regulation ensure authenticity by banning synthetic pesticides, GMOs, and chemical fertilizers.
Key alternatives to organic fruits and vegetables include conventionally grown produce, as well as processed or preserved options like canned or frozen offerings. Specialty or exotic fruits not offered in organic form may also serve as substitutes.
Consumers driving demand include those focused on health, those motivated by sustainability, and individuals with dietary preferences such as vegan or plant-based diets.

Key Companies List

Amy’s Kitchen
The Hain Celestial Group
General Mills Inc.
Conagra Brands
Danone S.A.
Driscoll’s, Inc.
SunOpta, Inc.
Del Monte Foods, Inc.
Organic Valley
Dole Food Company, Inc.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion

In essence, the organic fruits and vegetables market is on a robust growth path, projected to nearly double in size—from USD 76.19 billion in 2023 to an estimated USD 147.31 billion by 2030—driven by consumer demand for healthier, safer, and more sustainable food choices. North America leads the charge, with organic fruits holding a dominant market share and supermarkets/hypermarkets serving as the primary distribution channel. Innovations in agriculture, environmental consciousness, and regulatory assurance underpin industry developments, while established global and regional companies shape competitive dynamics.

browse our blog: https://globalindustryherald.com

Organic Cheese Powder Market Gains Popularity in Nutritional Snacks

In 2023, the global organic cheese powder market was estimated at USD 319.66 million. Projections indicate it will reach USD 505.91 million by 2030, reflecting a compound annual growth rate of 6.8% from 2024 to 2030. This expansion is driven by growing consumer preferences for organic and natural food products, as well as the rising demand for convenient, flavor-enhancing ingredients across diverse culinary applications. The surge in health awareness and sustainability concerns is a key underpinning of this trend.

Key Market Trends & Insights

Europe accounted for over 40% of global organic cheese powder sales in 2023, led by consumer health consciousness and stringent organic standards across countries such as Germany, France, the UK, and the Netherlands.
In North America, the United States represented 84% of regional revenue in 2023, with high consumer demand for certifications such as USDA Organic, non-GMO, and gluten-free driving preference for organic variants.
Organic cheddar cheese powder held a dominant 48.03% revenue share in 2023, making it the largest product segment.
Among applications, snack products accounted for about 30% of revenue in 2023. Organic cheese powders are increasingly featured in snacks such as organic popcorn, pretzels, and crackers that cater to both taste and clean-label preferences.

Market Size & Forecast

2023 Market Size: USD 319.66 million
2030 Projected Market Size: USD 505.91 million
CAGR (2024–2030): 6.8%
Largest Market Region (2023): Europe

The market benefits from increased retail availability of organic cheese powders, clean-label consumer demand, and eco-friendly preferences. Certifications signaling organic authenticity and sustainable production are influential in purchasing decisions.

The trend is reinforced by product innovation such as flavor blends, herb-infused variants, and collaborations—melding convenience with diverse culinary profiles.

Order a free sample PDF of the Organic Cheese Powder Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insight

The market is characterized as fragmented but growing; innovation is accelerating with producers experimenting with varied flavor profiles and blends to meet evolving consumer tastes.

Substitutes—namely conventional cheese powders and vegan cheese powders—pose a moderate to high competitive threat due to cost and accessibility, though demand for organic credentials tempers the impact.

Key Companies:

Land O’Lakes, Inc.
Bluegrass Ingredients, Inc.
Glanbia plc
Cheesepop Food Group
Kerry Group plc
Outdoor Herbivore
Frontier Co-op
Healthier Comforts
Anthony’s Goods
Ballantyne

These firms hold leading positions in terms of market share and shape industry trends through organic product offerings and retail expansion.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion

The organic cheese powder market is on a robust growth trajectory, underpinned by a global shift toward organic, clean-label, and health-oriented food choices. With a solid base of USD 319.66 million in 2023 and poised to reach USD 505.91 million by 2030 (at a 6.8% CAGR), the industry reflects dynamic regional leadership—Europe at the forefront, and North America closely following. Cheddar dominates product share, while snack applications lead usage. Competitive intensity is rising, fuelled by both traditional and emerging substitutes, spurring innovation. The presence of diverse key players—from established agribusinesses to niche organic brands—indicates a maturing yet flexible market landscape. Looking ahead, sustained consumer demand for transparency, flavor, and convenience will likely continue to propel the sector’s expansion.

browse our blog: https://globalindustryherald.com

Oral Appliances Market Supported by Advanced 3D Printing Solutions

In 2023, the global oral appliance market was valued at USD 908.7 million. It is projected to grow at a compound annual growth rate (CAGR) of 5.72% from 2024 to 2030, reaching around USD 1.4 billion by 2030. This expansion is driven by growing awareness of sleep-related disorders, especially obstructive sleep apnea (OSA), as well as increased demand for non-invasive treatments. Technological advancements, better product design focused on comfort, supportive reimbursement frameworks, and the presence of established market participants all contribute to the market’s upward trajectory

Key Market Trends & Insights

Geographic leadership: North America held the largest revenue share in 2023, with the U.S. as the primary contributor
Product dominance: Mandibular advancement devices (MADs) accounted for the largest share of the market, representing 69.0% of revenue in 2023
Distribution channels: The direct-to-consumer (DTC) segment led sales, capturing the largest share among distribution methods
End-use segment: Hospitals and clinics were the main purchasers of oral appliances in 2023

Broader enhancements: Market growth is also fueled by technological innovation—such as 3D printing and smart-device integration—improvements in comfort, favorable policies, and support for alternatives to CPAP therapy

Demographic influence: The rising global geriatric population significantly contributes to market demand. OSA affects 13% to 32% of individuals aged 65 and older, and with the elderly population expected to double in share—from 12% to 22%—its impact is substantial

Market Size & Forecast

2023: Market valued at USD 908.7 million
2024 (estimate): Approximately USD 970.7 million
2030 projection: Around USD 1.4 billion, based on a 5.72% CAGR from 2024 to 2030
Regional drivers: North America remains the largest market, while Europe and Asia Pacific are expected to register significant growth.

Europe benefits from increased awareness and evolving technologies; Asia Pacific gains momentum through awareness expansion, improved healthcare infrastructure, and events showcasing new developments

Order a free sample PDF of the Oral Appliances Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insight

These companies contribute through innovations, product launches, regulatory approvals, and geographic expansion. For example, in November 2022, one company received U.S. FDA clearance for a newly refined appliance that was notably more compact—by nearly 13%—than previous models, aligning with Centers for Medicare Services (CMS) coding guidelines

Key Companies

ResMed Inc.
ProSomnus
Vivos Therapeutics
SomnoMed
Glidewell
Airway Management (TAP)
Mitsui Chemicals, Inc. (Whole You)
Achaemenid, LLC
Apnea Sciences
Signifier Medical Technologies

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion

Overall, the oral appliances market is on a steady growth path, poised to expand from USD 908.7 million in 2023 to around USD 1.4 billion by 2030. This momentum is primarily underpinned by rising awareness of sleep apnea, especially among aging populations, preference for less invasive solutions, and sustained technological advancements. North America continues to lead the market, but robust growth is expected in Europe and Asia Pacific, driven by increased healthcare investments and innovation showcases. Leading firms in this field are front and center—innovating in device design, securing regulatory endorsements, and refining channels to meet evolving patient needs.

browse our blog: https://globalindustryherald.com

Microcarriers Market Advances Due to Demand in Biologics Development

The global microcarriers market size was estimated at USD 1,945.7 million in 2024 and is projected to reach USD 3,500.8 million by 2030, growing at a CAGR of 10.5% from 2025 to 2030. This market growth is primarily attributed to the high demand for cell-based vaccines and therapeutics.

The increasing incidence of diseases such as diabetes, cancer, rheumatoid arthritis, and hemophilia, alongside significant investments in innovative therapy development and advancements in cell biology research, is fueling market expansion. For example, in May 2024, Sartorius partnered with Sanofi to co-develop a platform that enhances downstream bioprocessing, potentially advancing microcarrier-based technologies for efficient biopharmaceutical production.

The growing demand for cell-based vaccines and therapeutics remains a central driver of the market. These products offer targeted and effective treatment options for diseases like cancer and infectious disorders. Microcarriers are integral to this process, as they provide a supportive surface for large-scale cell culture expansion—crucial for vaccine and therapeutic manufacturing.

As the global population continues to age and expand, the prevalence of chronic and infectious diseases also rises. This demographic shift further accelerates the demand for novel cell-based treatments that utilize microcarriers for scalable and efficient cell culture.

Large-scale investments from pharmaceutical companies, biotech firms, and research institutions are driving innovation in cell-based therapies. These investments aim to develop scalable solutions using microcarriers for applications such as vaccines, gene therapies, and regenerative medicine. For instance, Eppendorf has focused on microcarrier-based systems to boost production efficiency and scalability.

Moreover, continuous technological advancements in cell biology research are enhancing the capabilities of microcarrier systems. Innovations in cell culture methods, bioreactor technologies, imaging, and biomaterials have significantly improved our understanding of cellular behavior, allowing for greater reproducibility and efficiency in manufacturing.

Order a free sample PDF of the Microcarriers Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights:

Regionally, North America generated the highest revenue in 2024.
Country-wise, China is projected to record the highest CAGR from 2025 to 2030.
Segment-wise, microcarrier beads generated USD 1,374.2 million in revenue in 2024.
Consumables, especially microcarrier beads, are expected to be the fastest-growing segment through 2030.

Market Size & Forecast:

2024 Market Size: USD 1,945.7 Million
2030 Projected Market Size: USD 3,500.8 Million
CAGR (2025–2030): 10.5%
North America: Largest regional market in 2024

Key Microcarrier Company Insights:

The microcarriers market is witnessing strong momentum due to continuous innovation and the increasing application of advanced technologies in cell biology. The growing need for effective disease treatments has created numerous opportunities in the cell therapy space. New market entrants and existing players are launching advanced solutions to meet evolving demands. For instance, in September 2023, Thermo Fisher Scientific introduced Gibco CTS Detachable Dynabeads—a new technology designed to streamline cell therapy manufacturing in clinical and commercial settings. The entry of such technologies intensifies market competition and accelerates innovation across the industry.

Key Players in the Microcarriers Market:

Thermo Fisher Scientific, Inc.
Merck KGaA
Danaher Corporation
Sartorius AG
Corning Incorporated
Eppendorf SE
Bio-Rad Laboratories, Inc.
HiMedia Laboratories Pvt. Ltd.
denovoMATRIX GmbH

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global microcarriers market is set for robust growth driven by rising healthcare needs, advancements in cell-based therapies, and strong R&D investments. With chronic and infectious diseases on the rise, and continuous technological progress, microcarriers are becoming indispensable in large-scale bioproduction. The competitive landscape is also intensifying as established players and new entrants alike strive to introduce efficient, scalable, and innovative solutions, positioning the microcarriers market as a key component of the future biotechnology ecosystem.

Microbial Identification Market Fueled by Growing Awareness of Pathogen Detection

The global microbial identification market size was valued at USD 4.19 billion in 2024 and is expected to reach USD 8.18 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.91% from 2025 to 2030. This significant growth is attributed to the rising prevalence of infectious diseases, rapid technological advancements, increased R&D efforts, and growing government investments in the biotechnology and life sciences sectors.

Moreover, heightened awareness regarding food safety and the need for effective environmental monitoring are key drivers anticipated to further fuel the market’s growth from 2025 onward. These factors are increasingly prompting industries and governments to adopt advanced microbial identification systems to ensure public health and safety.

Antimicrobial resistance (AMR)—the ability of microbes to resist the effects of medications—poses a serious global health threat. It leads to higher mortality rates, extended hospitalizations, and escalating healthcare costs. Accurate microbial identification plays a crucial role in combatting AMR by enabling precise, targeted treatment and minimizing the inappropriate use of broad-spectrum antibiotics.

With healthcare systems placing greater emphasis on antimicrobial stewardship, the demand for rapid and accurate microbial diagnostics is rising. Technologies like MALDI-TOF mass spectrometry, PCR-based systems, and next-generation sequencing (NGS) offer efficient detection of pathogens and resistant strains, allowing clinicians to make informed decisions and enhance patient outcomes. These tools are becoming essential components of modern infection control and treatment strategies.

According to the Global Research on Antimicrobial Resistance Project published in The Lancet in September 2024, the absence of effective interventions could result in over 39 million direct deaths from antibiotic-resistant bacterial infections within the next 25 years. Indirect deaths could reach an additional 169 million. By 2050, total deaths from AMR are projected to surge to 10.13 million annually, with an economic impact potentially reaching $1 trillion to $3.4 trillion in global GDP losses by 2030. These projections underscore the urgent need for reliable microbial identification methods.

International initiatives, such as the World Health Organization’s Global Action Plan on AMR, are encouraging governments to enhance surveillance systems and diagnostic infrastructures. In response, hospitals, research institutions, and laboratories are increasingly investing in advanced microbial identification technologies, reinforcing the market’s critical role in public health.

Order a free sample PDF of the Microbial Identification Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

North America led the global market with a 38.38% share in 2024.
The U.S. microbial identification market is anticipated to witness strong growth throughout the forecast period.
Consumables dominated the product & services segment with a 36.60% share in 2024.
PCR technology accounted for the largest technology segment with a 36.69% share in 2024.
The genotypic segment held the largest share at 42.19% in 2024 and is expected to record the highest CAGR from 2025 to 2030.

Market Size & Forecast

2024 Market Size: USD 4.19 Billion
2030 Market Size: USD 8.18 Billion
CAGR (2025–2030): 11.91%
North America: Largest regional market (2024)
Asia Pacific: Fastest-growing region

Key Microbial Identification Company Insights

Leading market participants are employing strategies such as partnerships, mergers, and geographical expansions to enhance their footprint and drive product accessibility. These initiatives play a vital role in shaping industry dynamics and accelerating market growth.

Major Companies in the Microbial Identification Market:

bioMérieux SA
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Bruker Corporation
Danaher Corporation
Qiagen N.V.
Charles River Laboratories
Wickham Micro Limited
VWR International LLC (Avantor Inc.)
Shimadzu Corporation
Merck KGaA
Eurofins Scientific SE
Biolog Inc

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion

The microbial identification market is poised for substantial growth through 2030, driven by the convergence of health priorities, technological progress, and global efforts to mitigate antimicrobial resistance. As awareness of microbial threats continues to grow, so too does the demand for accurate and timely identification tools. The integration of advanced technologies, coupled with supportive government and institutional initiatives, ensures that microbial identification will remain a cornerstone in the global strategy to protect public health, improve patient care, and curb the economic and medical impact of AMR.

U.S. Nuclear Medicine Market Boosted by Cancer and Neurology Applications

The U.S. nuclear medicine market size was estimated at USD 5.1 billion in 2023 and is projected to grow at a CAGR of 12.6% from 2024 to 2030. This growth is primarily driven by the increasing prevalence of cancer and cardiovascular diseases across the country. According to the American Cancer Society, the U.S. recorded approximately 1,958,310 new cancer cases in 2023, with 609,820 projected cancer-related deaths. The demand for nuclear medicine is further fueled by technological advancements and the growing need for precise diagnostic and treatment solutions.

Cardiovascular diseases remain the leading cause of death among most racial and ethnic groups in the U.S. As per a CDC report published in May 2023, around 805,000 Americans experience heart attacks annually, with 605,000 undergoing their first episode. To combat this, the U.S. government allocated nearly USD 239 billion annually between 2018 and 2019 for heart disease prevention and treatment, encompassing medication and healthcare services. Lifestyle factors such as alcohol consumption, unhealthy diets, and physical inactivity contribute significantly to the prevalence of cancer and heart diseases, thereby escalating the demand for nuclear medicine solutions.

The market is further driven by continuous technological innovation. Radiopharmaceuticals have transformed diagnostic and therapeutic practices in cardiology and oncology. Ongoing research highlights the efficacy of radioisotopes in treating a variety of health conditions, including cancer, thyroid disorders, respiratory ailments, bone issues, and gastrointestinal diseases. This scientific momentum is leading to the development of advanced nuclear medicine products for diagnostic and therapeutic use. For example, Siemens Healthineers introduced the Symbia Pro.specta in June 2022—an advanced SPECT and CT imaging system—which received both U.S. FDA clearance and CE mark approval for broad clinical application. Its features include automated workflows, SPECT motion correction for improved imaging, and a low-dose CT of up to 64 slices, setting it apart in the competitive landscape.

The demand for accurate diagnostic tools continues to rise, with Positron Emission Tomography (PET) gaining traction due to its precision in targeted organ analysis. PET scans offer superior accuracy compared to traditional diagnostic methods and are instrumental in evaluating treatment efficacy. Frequently combined with X-rays or CT scans, PET enhances diagnostic detail. In October 2023, Positrigo AG launched its NeuroLF PET system in the U.S. via its local subsidiary, reinforcing the importance of R&D and innovation in nuclear imaging technologies.

Order a free sample PDF of the U.S. Nuclear Medicine Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

By Product: Diagnostic products held a dominant share, accounting for 71.2% of total revenue in 2023.
By End-use: Hospitals and clinics were the leading end-users in 2023.
By Application: The oncology segment led the market by application share in 2023.

Market Size & Forecast

2023 Market Size: USD 5.1 billion
2030 Projected Market Size: USD 12.27 billion
CAGR (2024–2030): 12.6%

Key U.S. Nuclear Medicine Company Insights

Prominent market players such as GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Siemens Healthineers AG, and Novartis leverage established regional networks to maintain stringent quality standards and secure competitive market shares. These companies invest significantly in advanced technologies and infrastructure to support high-volume diagnostics and therapies. Strategic partnerships and distributor collaborations further strengthen their positions.

Emerging players like NTP Radioisotopes SOC Ltd., Eczacıbaşı-Monrol, Lantheus Medical Imaging, and Nordion (Canada), Inc. are gaining visibility by securing government and institutional funding and launching novel products to address unmet needs in the U.S. market.

Key U.S. Nuclear Medicine Companies:

Eckert & Ziegler
Curium
GE Healthcare
Jubilant Life Sciences Ltd.
Bracco Imaging S.P.A
Nordion (Canada), Inc.
The Institute for Radioelements (IRE)
NTP Radioisotopes SOC Ltd.
Eczacıbaşı-Monrol
Lantheus Medical Imaging, Inc.
The Australian Nuclear Science and Technology Organization
Novartis (Advanced Accelerator Applications)
Siemens Healthineers AG

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The U.S. nuclear medicine market is poised for substantial growth due to a convergence of factors, including the rising burden of cancer and cardiovascular diseases, rapid technological innovations, and increasing investment in advanced imaging and therapeutic solutions. The adoption of highly accurate diagnostic tools such as PET and SPECT systems, combined with robust R&D activities and supportive government initiatives, will continue to drive the market forward. As major and emerging players expand their capabilities and partnerships, the landscape is set to evolve with new innovations catering to the growing demand for personalized and efficient healthcare solutions.